SCHEMBL3669009

SCHEMBL3669009

CCCCCCCC/C=C\CCCCCCCC(=O)N(CC)CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 3/20 0.61
PTPN1 P18031 3/20 0.61
PPARG P37231 3/20 0.61
PPARD Q03181 3/20 0.61
PPARA Q07869 3/20 0.61
CYP1A2 P05177 2/20 0.61
MAPT P10636 2/20 0.61
CYP2C19 P33261 2/20 0.61
BLM P54132 2/20 0.61
HSD17B10 Q99714 2/20 0.61
FABP4 P15090 2/20 0.61
FAAH O00519 2/20 0.61
KMT2A Q03164 2/20 0.61
GMNN O75496 1/20 0.61
USP2 O75604 1/20 0.61
LMNA P02545 1/20 0.61
POLB P06746 1/20 0.61
CYP2C9 P11712 1/20 0.61
ALOX15 P16050 1/20 0.61
APEX1 P27695 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766327 1.00 TERT (0.61) TERTPTPN1PPARGPPARDPPARA
SCHEMBL3431754 1.00 TERT (0.61) TERTPTPN1PPARGPPARDPPARA
SCHEMBL3431750 1.00 TERT (0.61) TERTPTPN1PPARGPPARDPPARA
SCHEMBL3765871 1.00 TERT (0.61) TERTPTPN1PPARGPPARDPPARA
SCHEMBL8766330 1.00 TERT (0.61) TERTPTPN1PPARGPPARDPPARA
SCHEMBL15615288 0.96 F7 (0.61) TERTPTPN1PPARGPPARDPPARA
Phosphoric Acid SCHEMBL4614885 0.95 FABP3 (0.59) TERTPTPN1PPARGPPARDPPARA
SCHEMBL5421518 0.95 ALDH1A1 (0.65) PPARGPPARDPPARAHSD17B10FABP4
Phosphoric Acid SCHEMBL29013110 0.95 FABP3 (0.59) TERTPTPN1PPARGPPARDPPARA
Ethylenediamine SCHEMBL28104684 0.93 FAAH (0.59) TERTPTPN1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230052708-A1 NON-REWETTING O/W (OIL IN WATER) EMULSIFICATION SYSTEM FOR HYDROPHOBIC COMPOUNDS ORGANOCLICK AB (SE) 2023-02-16 US claimed
EP-4018266-A1 METHOD FOR MAKING LITHOGRAPHIC PRINTING PLATES Eastman Kodak Company (US) 2022-06-29 EP claimed
US-20210221116-A1 METHOD FOR MAKING LITHOGRAPHIC PRINTING PLATES BANK OF AMERICA, N.A., AS AGENT 2021-07-22 US claimed
EP-3297621-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE Dublin City University (IE) 2018-03-28 EP claimed
WO-2016185025-A1 A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE DUBLIN CITY UNIVERSITY (IE) 2016-11-24 WO claimed
US-5250108-A Mixture of salicylic acid salt, amide and sulfonamide compounds KANZAKI PAPER MANUFACTURING CO. LTD. (JP) 1993-10-05 US claimed
US-3974196-A Method for disproportionating ethylenically unsaturated compounds having functional ester groups JAPAN SYNTHETIC RUBBER CO., LTD. (JA) 1976-08-10 US claimed
EP-4692260-A1 KIT FOR THREE-COMPONENT COATING COMPOSITION, THREE-COMPONENT COATING COMPOSITION, AND IN-MOLD COATING METHOD Kansai Paint Co., Ltd (JP) 2026-02-11 EP disclosed
US-20260021615-A1 COATING COMPOSITION AND IN-MOLD COATING METHOD KANSAI PAINT CO LTD (JP) 2026-01-22 US disclosed
WO-2025070002-A1 COATING MATERIAL COMPOSITION AND IN-MOLD COATING METHOD 関西ペイント株式会社 2025-04-03 WO disclosed
CN-119546715-A Coating composition and in-mold coating method 关西涂料株式会社 2025-02-28 CN disclosed
WO-2024203429-A1 KIT FOR THREE-COMPONENT COATING COMPOSITION, THREE-COMPONENT COATING COMPOSITION, AND IN-MOLD COATING METHOD 関西ペイント株式会社 2024-10-03 WO disclosed
WO-2024018730-A1 COATING COMPOSITION AND IN-MOLD COATING METHOD 関西ペイント株式会社 2024-01-25 WO disclosed
US-5120777-A Organonitrogen compound as coupler ELF FRANCE (FR) 1992-06-09 US disclosed
EP-0421973-A1 Stabilized polyacetal compositions and method for their preparation SOLVAY (BE) 1991-04-10 EP disclosed
EP-0409683-A1 Bitumen/polymer composition with a stable adhesiveness when stored at high temperature and method of its manufacture ELF ANTAR FRANCE (FR) 1991-01-23 EP disclosed
WO-1991000315-A1 BITUMEN/POLYMER COMPOSITION WITH AN ADHESIVE STRENGTH PRESERVED DURING STORAGE AT HIGH TEMPERATURE AND PROCESS FOR ITS PREPARATION ELF FRANCE (FR) 1991-01-10 WO disclosed
US-4217299-A Method for converting unsaturated compound having functional group JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1980-08-12 US disclosed
US-4171975-A MAGENTA COUPLER AND AN AMIDE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1979-10-23 US disclosed
US-3974196-A Method for disproportionating ethylenically unsaturated compounds having functional ester groups JAPAN SYNTHETIC RUBBER CO., LTD. (JA) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021615-A1 COATING COMPOSITION AND IN-MOLD COATING METHOD VIM, VCL, C9 TERT 2072/4885PTPN1 4356/4885PPARG 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.